139 related articles for article (PubMed ID: 7786610)
1. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
Romain S; Lainé Bidron C; Martin PM; Magdelenat H
Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
[TBL] [Abstract][Full Text] [Related]
2. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
3. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
[No Abstract] [Full Text] [Related]
4. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
[TBL] [Abstract][Full Text] [Related]
5. EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of Cancer.
Sweep CG; Geurts-Moespot J
Int J Biol Markers; 2000; 15(1):62-9. PubMed ID: 10763143
[TBL] [Abstract][Full Text] [Related]
6. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms.
Cren H; Lechevrel C; Roussel G; Goussard J
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):519-27. PubMed ID: 1911441
[TBL] [Abstract][Full Text] [Related]
7. Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology.
Romain S; Spyratos F; Goussard J; Formento JL; Magdelénat H
Breast Cancer Res Treat; 1996; 41(2):131-9. PubMed ID: 8944331
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
Rhodes A; Jasani B; Balaton AJ; Miller KD
J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
[TBL] [Abstract][Full Text] [Related]
10. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.
Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM
Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
[TBL] [Abstract][Full Text] [Related]
12. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
13. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
[TBL] [Abstract][Full Text] [Related]
14. Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay.
Mobbs BG; Chapman JA; Sutherland DJ; Ryan E; Tustanoff ER; Ooi TC; Murthy PV
Eur J Cancer; 1993; 29A(9):1293-7. PubMed ID: 8343271
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor assays: an Italian quality assessment program.
Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
[TBL] [Abstract][Full Text] [Related]
18. Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study Group.
Geurts-Moespot J; Leake R; Benraad TJ; Sweep CG
Int J Oncol; 2000 Jul; 17(1):13-22. PubMed ID: 10853012
[TBL] [Abstract][Full Text] [Related]
19. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours.
Romain S; Dussert C; Martin PM
Eur J Cancer; 1991; 27(6):715-20. PubMed ID: 1829910
[TBL] [Abstract][Full Text] [Related]
20. Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.
Lerma E; Esqué C; Peiró G; Mora J; Cerdá I; Prat J
Scand J Clin Lab Invest; 1994 Dec; 54(8):591-4. PubMed ID: 7709160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]